These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8013765)

  • 1. Partial reversal by exercise of protective effect in atrial fibrillation inducibility in patients with an accessory atrioventricular connection: comparison between flecainide and propafenone.
    Auricchio A; Auricchio U; Chiariello L
    G Ital Cardiol; 1994 Feb; 24(2):131-6. PubMed ID: 8013765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible protective effect of propafenone or flecainide during atrial fibrillation in patients with an accessory atrioventricular connection.
    Auricchio A
    Am Heart J; 1992 Oct; 124(4):932-7. PubMed ID: 1529904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of anti-arrhythmic therapy guided by the transesophageal electropharmacologic test and emperic therapy in the prophylaxis of atrial fibrillation recurrence].
    Fera MS; Carunchio A; Burattini M; Mazza A; Coletta C; Galati A; Ceci V
    G Ital Cardiol; 1997 Feb; 27(2):152-63. PubMed ID: 9244718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
    Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
    Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome].
    Kieny JR; Kraenner C; Facello A; Roul G; Mossard JM; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
    Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
    Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
    G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation].
    Romano S; Fattore L; Toscano G; Corsini F; Coppo A; Catanzaro M; Romano A; Martone A; Caccavale F; Iodice E; Di Maggio O; Corsini G
    Ital Heart J Suppl; 2001 Jan; 2(1):41-5. PubMed ID: 11216083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern.
    Antunes E; da Silva N; Catarino C; Serra J; Galrinho A; Ferreira R; Quininha J; Gracias R; Rato JA
    Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M; Mangiameli S; Orazi S; Chiarandà G; Piccione G; Di Giovanni N; Colletti A; Pensabene O; Lisi F; Vasquez L; Grammatico A; Boriani G;
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
    O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: rate control often better than rhythm control.
    Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Propafenone, flecainide, procainamide in the treatment of a fresh attack of atrial fibrillation].
    Kosmala W; Kucharski W; Haczyński J; Kobusiak-Prokopowicz M
    Wiad Lek; 1994; 47(21-24):801-7. PubMed ID: 8999690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Outpatient treatment of recurrent atrial fibrillation with the "pill-in-the-pocket" approach: practical aspects].
    Alboni P; Botto GL; Baldi N
    Ital Heart J Suppl; 2005 Jun; 6(6):335-40. PubMed ID: 16013424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological cardioversion with intravenous propafenone in atrial fibrillation].
    Velázquez Rodríguez E; Cancino Rodríguez C; Arias Estrada S; Rangel Rojo J; Hernández Morales E; Uribe Muñoz A
    Arch Inst Cardiol Mex; 2000; 70(2):160-6. PubMed ID: 10932801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological cardioversion of isolated atrial fibrillation: recovery of atrial mechanical function and correlation with duration of arrhythmia].
    Bellandi F; Dabizzi RP; Mugnaioni G; Cantini F; Palchetti R
    G Ital Cardiol; 1997 Oct; 27(10):1029-35. PubMed ID: 9410773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of propafenone on arrhythmias induced by exertion in patients with ischemic cardiopathy].
    Patané S; Virga T; Giannetto M; Luzza F; Oreto G; Arrigo F
    G Ital Cardiol; 1987 Jul; 17(7):605-8. PubMed ID: 3678712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.